Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma von Casale, T. B., Chipps, B. E., Rosén, K., Trzaskoma, B., Haselkorn, T., Omachi, T. A., Greenberg, S., Hanania, N. A.

Volltext

Safety and tolerability of omalizumab von Corren, J., Casale, T. B., Lanier, B., Buhl, R., Holgate, S., Jimenez, P.

Volltext

A new perspective on concepts of asthma severity and control von Taylor, D. R, Bateman, E. D, Boulet, L-P, Boushey, H. A, Busse, W. W, Casale, T. B, Chanez, P, Enright, P. L, Gibson, P. G, de Jongste, J. C, Kerstjens, H. A. M, Lazarus, S. C, Levy, M. L, O'Byrne, P. M, Partridge, M. R, Pavord, I. D, Sears, M. R, Sterk, P. J, Stoloff, S. W, Szefler, S. J, Sullivan, S. D, Thomas, M. D, Wenzel, S. E, Reddel, H. K

Volltext

CYT003, a TLR9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study von Casale, T. B., Cole, J., Beck, E., Vogelmeier, C. F., Willers, J., Lassen, C., Hammann‐Haenni, A., Trokan, L., Saudan, P., Wechsler, M. E.

Volltext

Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allerg... von Schwartz, L.B, Delgado, L, Craig, T, Bonini, S, Carlsen, K.H, Casale, T.B, Del Giacco, S, Drobnic, F, van Wijk, R.G, Ferrer, M, Haahtela, T, Henderson, W.R, Israel, E, Lötvall, J, Moreira, A, Papadopoulos, N.G, Randolph, C.C, Romano, A, Weiler, J.M

Volltext

We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology von Lötvall, J., Pawankar, R., Wallace, D. V., Akdis, C. A., Rosenwasser, L. J., Weber, R. W., Wesley Burks, A., Casale, T. B., Lockey, R. F., Papadopoulos, N. G., Fineman, S. M., Ledford, D. K.

Volltext

Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis von Casale, Thomas B., Bernstein, I.Leonard, Busse, William W., LaForce, Craig F., Tinkelman, David G., Stoltz, Randall R., Dockhorn, Robert J., Reimann, James, Su, John Q., Fick, Robert B., Adelman, Daniel C.

Volltext

CD2 identifies a monocyte subpopulation with immunoglobulin E-dependent, high-level expression of FcεRI von CHENG, Y. X, FOSTER, B, HOLLAND, S. M, KLION, A. D, NUTMAN, T. B, CASALE, T. B, METCALFE, D. D, PRUSSIN, C

Volltext

Practical guide to skin prick tests in allergy to aeroallergens von Bousquet, J., Heinzerling, L., Bachert, C., Papadopoulos, N. G., Bousquet, P. J., Burney, P. G., Canonica, G. W., Carlsen, K. H., Cox, L., Haahtela, T., Lodrup Carlsen, K. C., Price, D., Samolinski, B., Simons, F. E. R., Wickman, M., Annesi-Maesano, I., Baena-Cagnani, C. E., Bergmann, K. C., Bindslev-Jensen, C., Casale, T. B., Chiriac, A., Cruz, A. A., Dubakiene, R., Durham, S. R., Fokkens, W. J., Gerth-van-Wijk, R., Kalayci, O., Kowalski, M. L., Mari, A., Mullol, J., Nazamova-Baranova, L., O'Hehir, R. E., Ohta, K., Panzner, P., Passalacqua, G., Ring, J., Rogala, B., Romano, A., Ryan, D., Schmid-Grendelmeier, P., Todo-Bom, A., Valenta, R., Woehrl, S., Yusuf, O. M., Zuberbier, T., Demoly, P.

Volltext

The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use von Barnes, P. J., Casale, T. B., Dahl, R., Pavord, I. D., Wechsler, M. E.

Volltext

Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium von Erger, R. A, Casale, T. B

Volltext

International consensus on (ICON) pediatric asthma von Papadopoulos, N. G., Arakawa, H., Carlsen, K.-H., Custovic, A., Gern, J., Lemanske, R., Le Souef, P., Mäkelä, M., Roberts, G., Wong, G., Zar, H., Akdis, C. A., Bacharier, L. B., Baraldi, E., van Bever, H. P., de Blic, J., Boner, A., Burks, W., Casale, T. B., Castro-Rodriguez, J. A., Chen, Y. Z., El-Gamal, Y. M., Everard, M. L., Frischer, T., Geller, M., Gereda, J., Goh, D. Y., Guilbert, T. W., Hedlin, G., Heymann, P. W., Hong, S. J., Hossny, E. M., Huang, J. L., Jackson, D. J., de Jongste, J. C., Kalayci, O., Aït-Khaled, N., Kling, S., Kuna, P., Lau, S., Ledford, D. K., Lee, S. I., Liu, A. H., Lockey, R. F., Lødrup-Carlsen, K., Lötvall, J., Morikawa, A., Nieto, A., Paramesh, H., Pawankar, R., Pohunek, P., Pongracic, J., Price, D., Robertson, C., Rosario, N., Rossenwasser, L. J., Sly, P. D., Stein, R., Stick, S., Szefler, S., Taussig, L. M., Valovirta, E., Vichyanond, P., Wallace, D., Weinberg, E., Wennergren, G., Wildhaber, J., Zeiger, R. S.

Volltext

Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis von Casale, Thomas B., Busse, William W., Kline, Joel N., Ballas, Zuhair K., Moss, Mark H., Townley, Robert G., Mokhtarani, Masoud, Seyfert-Margolis, Vicki, Asare, Adam, Bateman, Kirk, Deniz, Yamo, the Immune Tolerance Network Group

Volltext

TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent von Smart, S. J, Casale, T. B

Volltext

S31 Dupilumab reduces severe exacerbations across baseline disease characteristics in patients with elevated baseline type 2 biomarkers: the LIBERTY ASTHMA QUEST study von Busse, WW, Muñoz, X, Casale, TB, Paggiaro, P, Castro, M, Tohda, Y, Rice, MS, Deniz, Y, Rowe, P, Amin, N, Teper, A

Volltext

Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils von Lin, Henry, Boesel, Kevin M, Griffith, Daniel T, Prussin, Calman, Foster, Barbara, Romero, F.A, Townley, Robert, Casale, Thomas B

Volltext

Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper von Bousquet, J., Schünemann, H. J., Zuberbier, T., Bachert, C., Baena‐Cagnani, C. E., Bousquet, P. J., Brozek, J., Canonica, G. W., Casale, T. B., Demoly, P., Gerth van Wijk, R., Ohta, K., Bateman, E. D., Calderon, M., Dolen, W. K., Haughney, J., Lockey, R. F., Lötvall, J., O’Byrne, P., Spranger, O., Togias, A., Bonini, S., Camargos, P., Carlsen, K. H., Chavannes, N. H., Delgado, L., Durham, S. R., Fokkens, W. J., Fonseca, J., Haahtela, T., Kalayci, O., Kowalski, M. L., Larenas‐Linnemann, D., Li, J., Mullol, J., Naclerio, R., Papadopoulos, N., Passalacqua, G., Rabe, K. F., Pawankar, R., Ryan, D., Simons, F. E. R., Yorgancioglu, A., Agache, I., Aït‐Khaled, N., Annesi‐Maesano, I., Beghe, B., Ben Kheder, A., Blaiss, M. S., Boakye, D. A., Bouchard, J., Burney, P. G., Chan‐Yeung, M., Chuchalin, A. G., Custovic, A., Dahl, R., Denburg, J., Douagui, H., Emuzyte, R., Grouse, L., Humbert, M., Jackson, C., Johnston, S. L., Kaliner, M. A., Keith, P. K., Kim, Y. Y., Kuna, P., Le, L. T., Lemiere, C., Mahboub, B., Marshall, G. D., Mavale‐Manuel, S., Meltzer, E. O., Motala, C., Naspitz, C., Nekam, K., Niggemann, B., Okamoto, Y., Orru, M. P., Ouedraogo, S., Palkonen, S., Popov, T. A., Price, D., Rosado‐Pinto, J., Scadding, G. K., Sooronbaev, T. M., Stoloff, S. W., Toskala, E., Van Cauwenberge, P., Vandenplas, O., Van Weel, C., Viegi, G., Virchow, J. C., Wang, D. Y., Wickman, M., Williams, D., Yawn, B. P., Zar, H. J., Zernotti, M., Zhong, N.

Volltext

A Pragmatic Primary Practice Approach to Using Specific IgE in Allergy Testing in Asthma Diagnosis, Management, and Referral von Demoly, Pascal, Liu, Andrew H, Rio, Pablo Rodriguez del, Pedersen, Soren, Casale, Thomas B, Price, David

Volltext

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA‐GA2LEN statement von Bousquet, J., Schünemann, H. J., Bousquet, P. J., Bachert, C., Canonica, G. W., Casale, T. B., Demoly, P., Durham, S., Carlsen, K.‐H., Malling, H.‐J., Passalacqua, G., Simons, F. E. R., Anto, J., Baena‐Cagnani, C. E., Bergmann, K.‐C., Bieber, T., Briggs, A. H., Brozek, J., Calderon, M. A., Dahl, R., Devillier, P., Gerth van Wijk, R., Howarth, P., Larenas, D., Papadopoulos, N. G., Schmid‐Grendelmeier, P., Zuberbier, T.

Volltext

Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis von Meltzer, Eli O., Casale, Thomas B., Nathan, Robert A., Thompson, Ann K.

Volltext